Immunoproliferative Disorders

Subscribe to Selected New Research on Immunoproliferative Disorders

26 relevant articles (0 outcomes, 1 trials/studies) found for this Disease

Description: Disorders characterized by abnormal proliferation of primary cells of the immune system or by excessive production of immunoglobulins.

Also Known As:

Disorder, Immunoproliferative; Disorders, Immunoproliferative; Immunoproliferative Disorder

Disease Context: Research Results

Immune System Diseases: 1236

Immunoproliferative Disorders: 26

Lymphoproliferative Disorders: 2237

Hypergammaglobulinemia: 831

Paraproteinemias: 806

Related Diseases

1.	Waldenstrom Macroglobulinemia (Macroglobulinemia)
2.	Exophthalmos (Proptosis)
3.	Multiple Myeloma
4.	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
5.	Neoplasms (Cancer)

Experts

1.	Vossen, Mireille T M: 1 article (02/2004)
2.	van Baarle, Debbie: 1 article (02/2004)
3.	Roos, Marijke T L: 1 article (02/2004)
4.	Weel, Jan F L: 1 article (02/2004)
5.	Baars, Paul A: 1 article (02/2004)
6.	Kuijpers, Taco W: 1 article (02/2004)
7.	Wertheim-van Dillen, Pauline M E: 1 article (02/2004)
8.	van Lier, René A W: 1 article (02/2004)
9.	Davin, Jean-Claude: 1 article (02/2004)
10.	Gent, Mi-Ran: 1 article (02/2004)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Immunoproliferative Disorders:

1.	Staphylococcal Protein A (A, Protein)IBA 10/01/1978 - "Studies of such a protein from a patient with an unusual array of immunoproliferative disorders including Grave's disease with exophthalmos and Waldenstrom's macroglobulinemia indicate that the cryoprecipitating and cold agglutinating properties probably derive from the sam protein" 12/01/1988 - "Bence Jones protein (BJP), on screening investigation for serum and urine monoclonal immunoglobulins were studied in order to better define the spectrum of immunoproliferative disorders associated with such a protein abnormality" Order ALL the reference details at left...
2.	Immunoglobulins (Immunoglobulin)IBA 05/01/1994 - "Monoclonal immunoglobulin deposition disease, a complication of overtly malignant or apparently benign immunoproliferative disorders, is a severe disease featuring tissue deposition of monoclonal light, light and heavy, or heavy chains" 11/01/1993 - "The factors that might contribute to the formation of corneal crystalloidal deposits in immunoproliferative disorders are discussed, and include: 1) an inherent propensity for crystallization of some immunoglobulins or kappa-light chains, perhaps because of abnormal molecular structure; and 2) local factors in the cornea that might promote deposition and crystallization of immunoprotein, such as temperature, pH, the water content, and extracellular matrix components." 05/01/1992 - "Structurally abnormal immunoglobulins in human immunoproliferative disorders." 10/07/1985 - "Data relative to other immunoproliferative disorders are consistent with the hypothesis that the immunoglobulins play a key role in the regulation of the multiplication of lymphocytic cells." 02/01/1993 - "Heavy chain diseases (HCD) are immunoproliferative disorders characterized by the production of monoclonal immunoglobulin molecules composed of deleted heavy chains devoid of light chains" Order ALL the reference details at left...
3.	Immunoglobulin G (IgG)IBA 01/01/1977 - "Most of the bone marrow lymphocytes had membrane IgG. This case represents an intermediate form between myeloma and Waldenström's disease, thus supporting the unitarian concept of all the immunoproliferative disorders." 01/01/1986 - "Unstimulated peripheral blood mononuclear cells from patients with angiocentric T cell immunoproliferative disorders and concanavalin A-stimulated normal peripheral blood mononuclear cells secrete a phagocytosis-inducing factor (PIF) that induces a fivefold to 50-fold enhancement of phagocytosis of IgG-coated ox red blood cells by U937 cells" 01/01/1977 - "A case of immunoproliferative disorder with clinical features of Waldenström's disease but with an IgG-k instead of IgM serum M component is described" Order ALL the reference details at left...
4.	Immunoglobulin D (IgD)IBA 01/01/1982 - "An immunoproliferative disorder with M component IgD/lambda and a strong decrease of the other Ig classes in the serum is reported" 01/01/1982 - "Monoclonal immunoproliferative disorder of B-lymphocytes IgD/lambda changing from chronic lymphocytic leukaemia to myeloma and plasmacytic leukaemia pattern." 01/01/1974 - "Surface IgD in immunoproliferative disorders." Order ALL the reference details at left...
5.	AsbestosIBA 03/01/1985 - "Chronic antigenic stimulation by asbestos could predispose one to the immunoproliferative disorders seen in these patients" 02/15/1981 - "Chronic antigenic stimulation by asbestos could predispose one to the immunoproliferative disorder seen in this patient or be responsible for it" Order ALL the reference details at left...
6.	Muromonab-CD3 (Muromonab CD3)FDA Link 09/01/1987 - "Three groups of patients with immunoproliferative disorders (15 multiple myeloma, 11 non-Hodgkin's lymphoma, 21 chronic lymphocytic leukemia) were studied by immunological characterization and compared to a group of 20 normal subjects (controls) using anti-immunoglobulin coated polyacrylamide beads (T-B Quantigen test, QT), erythrocyte rosettes (ER), surface immunoglobulin (SIg), and monoclonal antibodies for T and B cells (OKT3; OKT11; OKT8; OKT4; IaDR); null cells (NC) and double marker (DM) cells were also considered" Order ALL the reference details at left...
7.	Prednisone (Sone)FDA LinkGeneric 06/01/1987 - "Deflazacort was substituted for Prednisone (based on the equivalence 1 mg Prednisone equals 1.2 mg Deflazacort), during maintenance glucocorticoid therapy in 9 children, 5 with renal diseases and 4 with connective tissue or immunoproliferative disorders" Order ALL the reference details at left...
8.	Nucleosomes (Nucleosome)IBA 07/01/1991 - "Thus the release of immunoproliferative nucleosomes form dying human lymphoid cells provides an autocrine lymphocyte stimulatory network which may be important in immunoproliferative disorders and in normal cell turnover" Order ALL the reference details at left...
9.	Myeloma ProteinsIBA 10/01/1967 - "M-components in immunoproliferative disorders" Order ALL the reference details at left...
10.	Lipoproteins (Lipoprotein)IBA 08/01/2005 - "INTRODUCTION: Multiple myeloma is a malignant immunoproliferative disorder with lipoprotein abnormalities" Order ALL the reference details at left...

Therapies and Procedures

1.	Transplants (Transplant) 07/01/1990 - "Epstein-Barr virus-related sequences were detected in the spleen of a patient with infectious mononucleosis, in lung and lymph node specimens from a patient with pulmonary manifestations of infectious mononucleosis, in various tissues from seven immunosuppressed organ transplant recipients with immunoproliferative disorders, and in small biopsy specimens from a patient with nasopharyngeal carcinoma" Order ALL the reference details at left...
2.	Homologous Transplantation (Allograft) 02/01/2004 - "Spontaneous outgrowth of EBV-transformed B-cells reflects EBV-specific immunity in vivo; a useful tool in the follow-up of EBV-driven immunoproliferative disorders in allograft recipients." Order ALL the reference details at left...
3.	Therapeutics 09/01/1989 - "Immunoproliferative disorders: detection, prevention, and therapeutics." Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Immunoproliferative Disorders

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 0 Outcomes
Top 200 Key Drugs and Biologics
Top 3 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>